Dr. Reyzan E. Shali, MD

Dr. Shali practices at Tri-City Primary Care Medical Group, Inc in Vista, California.

Dr. Shali's NPI, 1245245018, was assigned on July 30, 2006. Dr. Shali graduated from University of Baghdad College of Medicine in 1992. Dr. Shali holds California license A76230.

Dr. Shali's primary practice is Tri-City Primary Care Medical Group, Inc, at 1926 Via Ctr, Vista, CA 92081 in San Diego County. The practice phone is (760) 940-7000.

Dr. Shali's primary practice is Tri-City Primary Care Medical Group, Inc in Vista, California. Dr. Shali is also affiliated with Palomar Medical Center Downtown Escondido. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Shali to 1 more hospital, 5 home health agencies, 3 skilled nursing facilities, 2 hospices, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shali practices, 13 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Shali's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Shali is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Shali's licenses on file in 2 states: California and Michigan.

Dmand AI lists acid reflux, acne, acute gastroduodenitis, acute skin infection, adjustment disease, alcohol use disorders, aneurysm and anxiety among the conditions Dr. Shali treats.

CMS data shows 2,288 Medicare services from Dr. Shali across 18 procedure codes in 2024, for 484 Medicare patients. Medicare paid $170,163 for them.

CMS counts 484 Medicare patients who saw Dr. Shali in 2024. The largest group is 75 to 84, with 203 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shali's median patient age at 76, with 74% women.

In 2024, Dr. Shali wrote 7,592 Medicare Part D claims for 666 patients. 89% of them were for generic drugs. CMS names the drug for 6,832 of them, across 130 drugs with 11 or more claims each, at $483,151 in total drug cost. In 2023, CMS named 4,635 claims across 103 drugs.

Dr. Shali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shali as offering telehealth. CMS counts 34 procedures of removal of skin lesions by Dr. Shali, more than 69% of the clinicians it reports for that procedure.

CMS Open Payments shows 295 general payments to Dr. Shali from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $714.

Dr. Shali graduated from University of Baghdad College of Medicine in 1992.

Dr. Shali is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.